Kusuri No Aoki Holdings Co., Ltd.

3549.T
Pharmaceutical Retailers
2026/01/16 Updated
Market Cap: $2.9B (¥453.1B)
Stock Price: $30.11 (¥4,771)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding Status of Treasury Stock Acquisition (Based on Article 459, Paragraph 1 of the Companies Act and the Provisions of the Articles of Incorporation)

During the period from December 26 to December 31, 2025, no treasury stock acquisition was conducted; the number of shares acquired was 0 shares, and the acquisition cost was 0 yen.

Importance:
Page Updated: January 9, 2026
IR Disclosure Date: January 9, 2026

Key Figures

  • Maximum Number of Shares Acquirable: 6,000,000 shares (6.32% of total outstanding shares)
  • Maximum Acquisition Cost: 24,000,000,000 yen
  • Acquisition Record from December 26 to December 31, 2025: 0 shares, 0 yen

AI要約

Overview of Treasury Stock Acquisition

Kusuri no Aoki Holdings Co., Ltd. planned to conduct a treasury stock acquisition based on a board resolution held on December 25, 2025, in accordance with Article 459, Paragraph 1 of the Companies Act and the provisions of the Articles of Incorporation. The target was the company’s common shares, with an upper limit of 6,000,000 shares, an acquisition cost upper limit of 24,000,000,000 yen, and an acquisition period set from December 26, 2025 to December 25, 2026. The method of acquisition was market purchases on the Tokyo Stock Exchange.

Acquisition Status from December 26 to December 31, 2025

The treasury stock acquisition status based on the above board resolution during the period from December 26 to December 31, 2025, was 0 shares acquired and 0 yen acquisition cost, meaning no actual acquisition took place. The future acquisition status is unknown, and it is noted that some or all of the acquisition may not occur depending on market conditions.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.